Revenue jumped 26.9% from a year ago to $743.6 million, to beat the FactSet consensus of $652.7 million, amid particular strength in connected fitness products. The margin of the revenue beat was the ...

Dr. Ronald P. Benitez, a neurosurgeon at Atlantic Brain and Spine, will present safety and outcomes data from the largest, ...

LEHI, Utah - Weave (NYSE: WEAV), a customer experience and payments software platform showing impressive momentum with a 54% gain over the past six months, has announced a collaboration with Prompt, a ...

Edgewise Therapeutics , Inc. (NASDAQ:EWTX), with a market capitalization of $2.67 billion, is a biopharmaceutical company focused on developing innovative therapies for severe, rare muscle disorders.

Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of ...

Vantive, formerly the Baxter Kidney Care segment, launched as a new standalone vital organ therapy company following the completion of its ...

We recently compiled a list of the 12 Best S&P 500 Stocks to Invest in According to Analysts. In this article, we are going to take a look at where Biogen Inc.